Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01858571Phase 3Completed
A Phase 3 trial of thalidomide, celecoxib oral solution, etoposide, cyclophosphamide in malignant neoplasm, sponsored by AIIMS New Delhi. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01858571.